Skip to main content

Table 2 Cox proportional hazards regression analyses for the risk of dementia among patients with lower urinary tract symptoms and different cumulative defined daily doses of therapeutic bladder anticholinergics

From: Cumulative use of therapeutic bladder anticholinergics and the risk of dementia in patients with lower urinary tract symptoms: a nationwide 12-year cohort study

 

Univariate model

Multivariate model

HR

(95% CI)

P

HR

(95% CI)

P

cDDD category

  < 28

1.00

  

1.00

  

 28–84

0.86

(0.70–1.05)

0.127

0.88

(0.73–1.06)

0.178

 85–336

1.11

(0.94–1.32)

0.221

1.15

(0.97–1.37)

0.107

  ≥ 337

1.39

(1.10–1.76)

0.006

1.40

(1.12–1.75)

0.004

Age (years)

1.08

(1.08–1.09)

< 0.001

1.08

(1.08–1.09)

< 0.001

Sex

 Male

1.00

  

1.00

  

 Female

1.16

(1.02–1.31)

0.023

1.35

(1.19–1.53)

< 0.001

Catastrophic illness certificate

1.54

(1.35–1.76)

< 0.001

1.24

(1.09–1.42)

0.001

Comorbidities

 Diabetes mellitus

1.23

(1.04–1.46)

0.018

1.15

(0.96–1.37)

0.121

 Hyperlipidemia

1.24

(0.84–1.83)

0.274

1.53

(1.04–2.24)

0.029

 Hypertension

1.20

(1.03–1.41)

0.023

0.96

(0.82–1.13)

0.659

 CAD

0.99

(0.72–1.36)

0.963

0.72

(0.53–0.97)

0.034

 CVD

2.46

(1.89–3.21)

< 0.001

1.92

(1.46–2.52)

< 0.001

 Atrial fibrillation

2.21

(1.18–4.12)

0.013

1.41

(0.75–2.63)

0.281

Number of outpatient visits per year

1.01

(1.01–1.02)

< 0.001

1.01

(1.00–1.01)

< 0.001

  1. CAD Coronary artery disease, cDDDs Cumulative defined daily doses, CI Confidence interval, CVD Cerebrovascular disease, HR Hazard ratio.